echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The curtain on the fifth batch of centralized procurement of drugs with a large amount has begun, and policy efforts have continued to deepen

    The curtain on the fifth batch of centralized procurement of drugs with a large amount has begun, and policy efforts have continued to deepen

    • Last Update: 2021-06-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On May 8, 2021, the National Organization Drug Joint Procurement Office issued the "Notice on Carrying out the Fifth Batch of National Organization Drug Centralized Procurement of Drug Information Collection", requiring relevant units to organize information declaration work.


    On May 8, 2021, the National Organization Drug Joint Procurement Office issued the "Notice on Carrying out the Fifth Batch of National Organization Drug Centralized Procurement of Drug Information Collection", requiring relevant units to organize information declaration work.


    Due to the huge impact of centralized procurement on the pharmaceutical industry, there have been endless discussions about "whether centralized procurement can be sustained".


    In the fifth batch of centralized procurement lists, the most interesting is the inclusion of many injections, including drugs such as ceftriaxone and levofloxacin, which are widely used clinically.


    In the early stage of mass collection, the selected varieties were mainly oral tablets, because of their reliable quality, strong safety, and a more mature consistency (bioequivalence) evaluation method to assist in the selection of varieties.


    With the advancement of the evaluation of the consistency of the quality and efficacy of injections, the centralized procurement of injection drugs has gradually begun.


    Of course, with the overall advancement of the centralized procurement work, longer-term and comprehensive institutional arrangements also need to have overall consideration and appropriate design.


    On the other hand, with the advancement of centralized procurement, the industry concentration of my country's pharmaceutical market will continue to increase.


    Centralized procurement of pharmaceuticals is a complex and difficult task, involving a wide range of interests and great social impact, and has also been questioned by many.



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.